AstraZeneca PLC
1452.00
23-ديسمبر-24 11:24:56
15 متأخرة بدقائق
الأسهم
+23.00
+1.61%
نطاق اليوم
1437.00 - 1458.00
ISIN
N/A
المصدر
Cboe
-
NetDania - New 12 months High: AstraZeneca PLC
23 يوليو 2024 06:15:26 بحسب NetDania Notify
-
NetDania - New 12 months High: AstraZeneca PLC
22 يوليو 2024 08:17:57 بحسب NetDania Notify
-
Interesting AZN Put And Call Options For August 23rd
03 يوليو 2024 13:16:51 بحسب NASDAQ US Markets
-
AstraZeneca: CHMP Recommends Lynparza And Imfinzi Combination For EU Approval In Endometrial Cancer
01 يوليو 2024 03:09:21 بحسب NASDAQ US Markets
-
Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN
28 يونيو 2024 10:33:02 بحسب NASDAQ Stocks
-
AstraZeneca: Imfinzi Trial Fails To Meet Endpoint In Early-stage Non-small Cell Lung Cancer
25 يونيو 2024 03:08:02 بحسب NASDAQ US Markets
-
AstraZeneca: Phase III Truqap Trial Plus Chemotherapy Fails To Meet Primary Goals In Breast Cancer
18 يونيو 2024 03:15:21 بحسب NASDAQ US Markets
-
AstraZeneca's Calquence Combo Cuts Progression Risk By 27% In Mantle Cell Lymphoma Trial
16 يونيو 2024 12:33:03 بحسب NASDAQ US Markets
-
FDA Approves AstraZeneca's Farxiga For Pediatric Use In Type-2 Diabetes
12 يونيو 2024 21:53:19 بحسب NASDAQ US Markets
-
NetDania - New 12 months High: AstraZeneca PLC
10 يونيو 2024 03:21:31 بحسب NetDania Notify
-
1 Biopharma Stock Setting the New Standard in Cancer Care Drugs
07 يونيو 2024 12:13:02 بحسب NASDAQ Stocks
-
Summit Therapeutics, AstraZeneca And More From The Year’s Biggest Cancer Conference
05 يونيو 2024 19:29:29 بحسب Forbes - World
-
AstraZeneca Completes Acquisition Of Fusion Pharma
05 يونيو 2024 03:08:45 بحسب NASDAQ US Markets
-
CHMP Recommends Approval Of AstraZeneca's Tagrisso Combo For EGFR-Mutated Advanced Lung Cancer
03 يونيو 2024 03:15:45 بحسب NASDAQ US Markets
-
Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris
30 مايو 2024 05:59:20 بحسب NASDAQ US Markets
-
AstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the Stock
29 مايو 2024 10:20:48 بحسب NASDAQ US Markets
-
AstraZeneca Plans to Rake in $80 Billion by 2030. Should You Buy the Stock?
29 مايو 2024 08:32:19 بحسب NASDAQ US Markets
-
AZN:Datopotamab Deruxtecan Shows Favorable Survival Results, Falls Short Of Statistical Significance
27 مايو 2024 02:59:14 بحسب NASDAQ US Markets
-
Pharma Stock Roundup: AZN's 2030 Sales Target, PFE's New Cost Cut Plan & More
24 مايو 2024 10:30:58 بحسب NASDAQ Stocks
-
NetDania - New 12 months High: AstraZeneca PLC
23 مايو 2024 10:35:27 بحسب NetDania Notify